Imagion Biosystems receives order related to cancer treatment

Imagion Biosystems receives order related to cancer treatment

Imagion Biosystems today announced that NewPhase Ltd., an Israeli biotechnology company developing cancer treatments, has issued an extended purchase order to Imagion Biosystems for the supply of nanoparticles for the remainder of 2019 to be used in the NewPhase product.

View the entire announcement here.


Related Articles

Successful Placement of A$3M

Imagion Biosystems (ASX: IBX) (Company), is pleased to announce the Company has received $3 million of firm commitments through a highly successful capital raising. The

Read More

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.